LumiraDx is a medical technology company that develops, manufactures, and commercializes point-of-care diagnostic tests. The company's platform technology is designed to deliver lab-comparable diagnostic results at the point of care, helping to improve patient outcomes and reduce healthcare costs.

LumiraDx

LumiraDx Limited

LumiraDx Limited operates as a point of care diagnostics company. The company focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers. It manufactures and commercializes a diagnostic platform that supports various tests with lab comparable performance at the point of care. The company has approximately 30 tests on the market and in development covering infectious diseases, cardiovascular diseases, diabetes, and coagulation disorders, as well as a portfolio of COVID-19 testing solutions from the lab to point of need. Its diagnostic testing solutions are deployed by governments and healthcare institutions across laboratories, urgent care, physician offices, pharmacies, schools, and workplaces to screen, diagnose, and monitor wellness, as well as disease. The company was founded in 2014 and is headquartered in London, the United Kingdom.

LumiraDx is a next-generation point of care diagnostics company that is transforming community-based healthcare. 

Founded in 2014, the company manufactures and commercializes an innovative diagnostic Platform that supports a broad menu of tests with lab comparable performance at the point of care. LumiraDx diagnostic testing solutions are being deployed by governments and leading healthcare institutions across laboratories, urgent care, physician offices, pharmacy, schools, and workplaces to screen, diagnose and monitor wellness as well as disease.  

The company has on the market and in development 30+ tests covering infectious diseases, cardiovascular disease, diabetes and coagulation disorders, all on the LumiraDx Platform. In addition, the company has a comprehensive portfolio of fast, accurate and cost-efficient COVID-19 testing solutions from the lab to point of need. 

COM:LUMIRADX

LumiraDx

Last Close

0.02

16/01 21:00

Volume Today

120.55M

Avg: -

name

homepage url

country

linkedin url

crunchbase url

employee count

sector

industry

revenue

Description

investor of

Metrics